Volker Lohmann - Infectious Diseases

Author Information

Volker Lohmann is a distinguished researcher in the field of Infectious Diseases, specifically focusing on virology. He is affiliated with the Department of Infectious Diseases, Molecular Virology at the University of Heidelberg, located in Heidelberg, Germany. His work is primarily centered on understanding the molecular mechanisms of virus replication and pathogenesis, with a significant emphasis on Hepatitis C virus (HCV).

Research Contributions

Volker Lohmann has made substantial contributions to the field of virology, particularly in the study of Hepatitis C virus. His research spans various aspects of HCV, including its replication mechanisms, pathogenesis, and potential therapeutic targets. Notable works include studies on the replication efficiency of HCV genotype 1b, the role of cellular lipid kinases in liver pathogenesis, and the interplay between HCV and host cellular mechanisms. His investigations into the replication organelles for both HCV and SARS-CoV-2 highlight his contributions to understanding virus-host interactions. Additionally, his work has played a critical role in drug development, evidenced by his research on the HCV replicon system and molecular chaperones as therapeutic targets.

Aliases

Volker Lohmann is also known by several aliases in the academic community, including V Lohmann and V. Lohmann.

Publication and Citation Metrics

Total Publications	177
Total Citations	18,644
H-index	66

Publications:

A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivo

DOI: 10.1101/2022.03.28.486019

Year: 2022

Contribution of the Cellular Lipid Kinase PI4KA to HCV-induced Liver Pathogenesis

DOI: 10.1055/s-0041-1740787

Year: 2022

Convergent use of phosphatidic acid for Hepatitis C virus and SARS-CoV-2 replication organelle formation

DOI: 10.1101/2021.05.10.443480

Year: 2021

Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation

DOI: 10.1038/s41467-021-27511-1

Year: 2021

Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses

DOI: 10.1038/s41467-021-25218-x

Year: 2021

The Hepatitis C Virus Replicon System and Its Role in Drug Development

DOI: 10.1007/7355_2018_34

Year: 2019

Indelibly Stamped by Hepatitis C Virus Infection: Persistent Epigenetic Signatures Increasing Liver Cancer Risk.

DOI: 10.1053/j.gastro.2019.04.033

Year: 2019

Evidence for Internal Initiation of RNA Synthesis by the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B In Cellulo

DOI: 10.1128/JVI.00525-19

Year: 2019

Inhibition of Hepatitis C Replication by Targeting the Molecular Chaperone Hsp90: Synthesis and Biological Evaluation of 4,5,6,7‐Tetrahydrobenzo[1,2‐d]thiazole Derivatives

DOI: 10.1002/cmdc.201800724

Year: 2019

SEC14L2, a lipid-binding protein, regulates HCV replication in culture with inter- and intra-genotype variations.

DOI: 10.1016/j.jhep.2018.11.012

Year: 2019

What is the Role of Vector Control in Combating Malaria?

How to Treat Rashes Caused by Infections?

Where is Yellow Fever Prevalent?

What is Rabies?

What Are Some Common Diseases Spread by Direct Contact?

What are the Risk Factors for HPV Infection?

What is the Prognosis for Infected Individuals?

What are Imaging Studies?

What are the challenges associated with DAAs?

What are the Objectives of the RBM Partnership?

Partnered Content Networks

Relevant Topics